Contact 
Locations .png){kind=icon}
Call Treatment Guide
Biologic Therapy
Biologics are targeted medicines that block specific immune pathways. They may be considered for selected patients with severe or difficult-to-control allergic and inflammatory conditions after diagnosis and standard treatment are reviewed.
Understanding Biologic Therapy
Biologic Therapy: what the first evaluation should clarify
Conditions treated with biologics
Depending on the medicine and approval, biologics may be used for severe asthma, chronic spontaneous hives, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis. A drug used for one condition is not automatically appropriate for another.
Candidacy and baseline review
The clinician considers diagnosis, age, symptom burden, flare history, prior treatment, biomarkers when relevant, other medical conditions, pregnancy plans, vaccination, and the ability to maintain scheduled dosing and follow-up.
Care Options
Administration, monitoring, and coverage
Biologics may be injected at home or in a clinical setting on schedules that vary by medicine. The care plan includes monitoring, storage, missed-dose instructions, and what to do after a reaction.
Insurance authorization and patient cost depend on the plan and diagnosis; approval is not guaranteed by scheduling a consultation.
Biologic Therapy planning questions
Build the biologic therapy next step from evidence
How a biologic is selected
Biologics target specific inflammatory pathways, so the diagnosis and phenotype matter. The review may include symptom control, exacerbations, steroid exposure, lung function, eosinophils or other biomarkers, nasal-polyps history, skin severity, prior treatments, and reasons those treatments were insufficient or unsuitable.
A medicine approved for several diseases is not automatically appropriate for every patient with one of those diagnoses. Age, comorbid conditions, dosing, pregnancy considerations, treatment goals, and access all affect the choice.
Set a measurable reassessment plan
Before treatment, define the outcomes that matter: fewer attacks, less oral-steroid exposure, improved sleep, reduced itch, better lung function, fewer hives, or improved ability to eat and function. Record a baseline so benefit and burden can be compared at the planned reassessment.
Biologics are maintenance treatments, not rescue therapy for an acute asthma attack or anaphylaxis. Continue the prescribed emergency and controller plans unless the treating clinician changes them.
Know the Next Step
Administration, safety, and continuity
Depending on the medicine and indication, doses may be given in a clinic or at home after training. Review storage, missed-dose instructions, injection technique, travel, vaccination questions, and which symptoms require a call or emergency care. Never share a device or improvise a dosing schedule.
Authorization and specialty-pharmacy delays can interrupt access, so start renewal planning before the approval expires and confirm how the medicine will be supplied.
Build a Measurable Treatment Plan
Before starting a biologic, define the disease target and follow-up measure
A biologic should be connected to a specific diagnosis and treatment goal, not chosen only because inflammation is described as severe. The evaluation distinguishes uncontrolled disease from poor technique, inconsistent controller use, ongoing exposure, a competing diagnosis, or a complication that needs a different intervention. For asthma, this may include exacerbation history and lung function; for hives, nasal polyps, eczema, or eosinophilic disease, the baseline measures are different.
Document the starting burden before the first dose: symptom frequency, sleep or activity limits, urgent visits, oral-steroid courses, affected body sites, and treatments already tried at an adequate dose and duration. The clinician also reviews infection history, vaccination questions, pregnancy plans, other immune-modifying medicines, and whether home or office administration is realistic. This record makes the later decision to continue, switch, or stop the medicine more defensible.
Coverage logistics should support the clinical plan rather than define it. Ask which diagnosis and prior-treatment records the authorization requires, how the dose will be supplied, and when renewal documentation is due. The biologic insurance guide explains those access questions separately from the treatment decision.
Questions About Biologic Therapy
Frequently Asked Questions About Biologic Therapy
How does an allergist choose among different biologics?
The choice depends on the confirmed condition, approved age and indication, disease pattern, prior treatment, relevant biomarkers, dosing schedule, safety considerations, and the outcome that will be measured. A medicine used for one allergic condition is not automatically appropriate for another.
Does starting a biologic replace my current medicines?
Not automatically. Controller medicines and emergency plans usually continue until the prescribing clinician reviews response and safely changes them. A biologic is maintenance treatment and does not replace rescue treatment for an acute asthma attack or anaphylaxis.
How soon should a biologic start working?
The expected timeline varies by medicine, diagnosis, and outcome. Some symptoms may change before others. The useful question is when the clinician plans to compare the agreed baseline measures and what amount of improvement would justify continuing treatment.
What should I do if a biologic dose is late or missed?
Follow the product-specific instructions from the prescribing team and contact them when the plan is unclear. Do not double a dose, shorten an interval, or restart after a long interruption based on general online advice.
Care Connected with Biologic Therapy
Evaluation and treatment related to Biologic Therapy
These diagnostic and treatment topics can shape a focused biologic therapy discussion.
Hives & Angioedema
Hives & Angioedema can clarify a separate question that often appears while evaluating Biologic Therapy.
View guideNasal Polyps Evaluation and Treatment
Use the Nasal Polyps Evaluation and Treatment guide to compare preparation, evidence, and next steps alongside Biologic Therapy.
View guideInsurance Coverage for Biologic Therapy
Open Insurance Coverage for Biologic Therapy for connected testing or treatment decisions that may follow a Biologic Therapy discussion.
View insurance guidePlan the next biologic therapy conversation
Bring the symptom, reaction, testing, and treatment records named in this Biologic Therapy guide so the visit can answer a focused question.
Treatment directory
Compare treatment options
Return to the treatment directory to compare therapies, testing pathways, and the questions to discuss before scheduling.
